Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 3:4:258.
doi: 10.3389/fgene.2013.00258.

Epigenetic alteration and microRNA dysregulation in cancer

Hiromu Suzuki  1 , Reo Maruyama  1 , Eiichiro Yamamoto  1 , Masahiro Kai  1
Affiliations
Review

Epigenetic alteration and microRNA dysregulation in cancer

Hiromu Suzuki et al. Front Genet. .

Abstract

MicroRNAs (miRNAs) play pivotal roles in numerous biological processes, and their dysregulation is a common feature of human cancer. Thanks to recent advances in the analysis of the cancer epigenome, we now know that epigenetic alterations, including aberrant DNA methylation and histone modifications, are major causes of miRNA dysregulation in cancer. Moreover, the list of miRNA genes silenced in association with CpG island hypermethylation is rapidly growing, and various oncogenic miRNAs are now known to be upregulated via DNA hypomethylation. Histone modifications also play important roles in the dysregulation of miRNAs, and histone deacetylation and gain of repressive histone marks are strongly associated with miRNA gene silencing. Conversely, miRNA dysregulation is causally related to epigenetic alterations in cancer. Thus aberrant methylation of miRNA genes is a potentially useful biomarker for detecting cancer and predicting its outcome. Given that many of the silenced miRNAs appear to act as tumor suppressors through the targeting of oncogenes, re-expression of the miRNAs could be an effective approach to cancer therapy, and unraveling the relationship between epigenetic alteration and miRNA dysregulation may lead to the discovery of new therapeutic targets.

Keywords: CpG island methylation; EZH2; biomarker; histone modification; microRNA; oncomir; tumor suppressor.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Epigenetic silencing of miRNA genes in cancer. Example of a miRNA gene with its CpG island. In normal cells, the CpG island is unmethylated, and the chromatin is associated with active histone modifications. In cancer cells, CpG island hypermethylation and repressive histone marks lead to epigenetic silencing of the miRNA gene (left). Alternatively, some miRNA genes are silenced through repressive histone modifications, rather than DNA methylation (right).
FIGURE 2
FIGURE 2
Dysregulation of miRNAs is causally related to epigenetic alterations in cancer. miRNAs able to negatively regulate DNMTs or EZH2 are frequently downregulated in cancer, which leads to epigenetic silencing of target genes.
See this image and copyright information in PMC

References

    1. Agirre X., Vilas-Zornoza A., Jimenez-Velasco A., Martin-Subero J. I., Cordeu L., Garate L., et al. (2009). Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69 4443–4453 10.1158/0008-5472.CAN-08-4025 - DOI - PubMed
    1. Alajez N. M., Shi W., Hui A. B., Bruce J., Lenarduzzi M., Ito E., et al. (2010). Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis. 1 e8510.1038/cddis.2010.64 - DOI - PMC - PubMed
    1. Ando T., Yoshida T., Enomoto S., Asada K., Tatematsu M., Ichinose M., et al. (2009). DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer 124 2367–2374 10.1002/ijc.24219 - DOI - PubMed
    1. Au S. L., Wong C. C., Lee J. M., Fan D. N., Tsang F. H., Ng I. O., et al. (2012). Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 56 622–631 10.1002/hep.25679 - DOI - PubMed
    1. Baer C., Claus R., Frenzel L. P., Zucknick M., Park Y. J., Gu L., et al. (2012). Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 72 3775–3785 10.1158/0008-5472.CAN-12-0803 - DOI - PubMed

LinkOut - more resources